adoptive cell transfer personalized immunotherapy human cancer 
adoptive cell therapy act highly personalized cancer therapy involves administration cancer-bearing host immune cells direct anticancer activity act using naturally occurring tumor-reactive lymphocytes mediated durable complete regressions patients melanoma probably targeting somatic mutations exclusive cancer results expanded reach act treatment common epithelial cancers addition ability genetically engineer lymphocytes express conventional t cell receptors chimeric antigen receptors extended successful application act cancer treatment 
